Barkat Pharmaceutical Group

Barkat Pharmaceutical Group (, Gruh-e Darvii-ye Berekât) is an Iranian Pharmaceutical public company, which was founded in 2010, named Tadbir innovation pharmaceutical company.[1] The company provides services through cooperation between science-based institutions and scientists based on medicine around the world.[2] It supplies 14 percent of all the country's essential drugs through its 25 subsidiaries.[3][4] The company produces 700 kinds of products in the pharmaceutical sector and offers it internally.[5]

The Barkat Pharmaceutical Group has established as the first specialized drug and pharmaceutical research center in Iran, also it has been developed by constructing advanced pharmaceutical factories, called Barkat Pharmaceutical Town.[6]

Activities

One of the activities of the Barkat Pharmaceutical Group is the building of a 200-hectare pharmaceutical town. Also, "cell therapy" by producing five products for the treatment of skin and heart disease and knee arthritis, production of "peptide medications" using in the treatment of high-dose diseases such as Multiple sclerosis, blood diseases and cancer, "Research and development and processing of medicinal plants", to use domestic capacities and prevent the sale of raw materials and entry into world markets, the "Museum of Iranian-Islamic medicine" to show the role of Iranian scientists in medicine, as well as the "Solids and Semi-Solids" projects to increase the production of various pharmaceutical products, are among other activities of the Barkat Pharmaceutical Group.[25]

Cell therapy

On May 15, 2018, the first factory for the production of stem cells in Western Asia (Cell Tech Pharmed) was inaugurated with the presence of Minister of Health and Medical Education Hassan Ghazizadeh Hashemi, and the First Vice President of Iran Eshaq Jahangiri[26][27][28] The factory, set up by Barkat Pharmaceutical Company and Royan Institute,[29] is a subsidiary of the Barkat Pharmaceutical Group[30] and is run by Cell Tech Pharmed, a company established in 2014 to work on stem cells, biotechnology, nanotechnology and pharmaceuticals.[26] It also manufactures products including Monocell, Ricollersal, Rhinooderm cell, etc. which are used to treat various cardiovascular, skin and skeletal diseases.[26][31]

In June 2025, 23 new drugs were unveiled in this complex, including seven for cancer treatment, six in the form of herbal supplements, and two products related to cell therapy. Some of these drugs were previously imported, while others had limited access within the country.[32]

Anticancer drugs

In order to provide anticancer drugs in the country, "Sobhan Chemotherapy products Company" (Sobhan Oncology Co, under the supervision of the Barkat Pharmaceutical Group )[33] was set up on 2002,[34] and launched in February 2010 with global standards.[35][36] The main activity of the company is the production of drugs for the treatment of cancer patients.[33] It is the first anti-cancer product manufacturer in the Middle East.[33][9]

Vaccines

COVIran Barekat is Iran's first domestic COVID-19 vaccine.[41] It's made by Shifa Pharmed Industrial Group, a subsidiary of Barkat Pharmaceutical Group.[41][42] Clinical trials began in December 2020[41][43] and the vaccine received emergency use authorization on 13 June 2021.[44] According to the Execution of Imam Khomeini's Order, about 8 million doses of COVIran Barekat have been produced up to 30 August 2021.[45]

Barkat Pharmaceutical Industrial Town

The Barkat Pharmaceutical Industrial Town[47] is a specialized pharmaceutical and research Town[15] Which was registered as the first pharmaceutical industrial park in the country[6][48] and the country's first Special Economic Pharmaceutical zone.[2] The site is located in Savojbolagh with area of 200 hectares, Alborz province, 60 km away from Tehran[48][49] and designed by international consultants and based on the latest standards of the world's pharmaceutical-industrial cities.[9] One of the main goal for the establishment of the Barkat Pharmaceutical Industrial Park is attracting $2 billion to finance a wide range of medical and pharmaceutical needs, including bio drugs, medical equipment, laboratory diagnostic kits and pharmaceutical packaging materials.[6] The pharmaceutical company's products are supplied locally and exported abroad.[50] Being High tech and ability to provide new services and innovations to the community are the main indicators of the acceptance of companies in the Barkat Industrial Pharmaceutical Town.[50] According to Najafi, Governor of Alborz, this site has presented more than 7,000 direct job opportunities.[2]

Capacities

In the Special Economic Pharmaceutical zone of Barkat, the appropriate space is anticipated for the deployment of pharmaceutical manufacturing companies in the fields of research and development and incubators, knowledge-based, cell therapy, biotechnology, gene therapy, blood and plasma refinement, vaccine, and also pharmaceutical companies and central warehouses. The Barkat Pharmaceutical Town also includes a cell factory with participation of the Royan Institute in the field of Cell Therapy and an international pharmacy university in PhD's degree to provide the required specialized personnel, researchers, and healthcare technologists.[48]

According to "Hamid Reza Jamshidi", the managing director of Barkat Pharmaceutical Group, 12% of the drugs of the Islamic Republic of Iran are produced in this pharmaceutical group.[51]

Herbal medicines

Mohammadi, director of the Alborz Pharmaceutical Company, said about a $2 billion investment in the production of herbal medicines by the Barakat Foundation. To this end, the specialized zone of medicine and health technologies is under construction in the Barkat Industrial Pharmaceutical Town.

type	Public company
industry	Pharmaceutical
founded	2010 in Tehran, Iran
area served	Asia
key people	Akbar Borandegi (CEO) Hamid Reza Jamshidi (Managing Director)
website	en.bpharmed.com

Barkat Pharmaceutical Group

Investment

Establishment

Director